Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
9.48
+0.29 (3.16%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Elanco Animal Health stock have an average target of 14.67, with a low estimate of 12 and a high estimate of 19. The average target predicts an increase of 54.75% from the current stock price of 9.48.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Total | 6 | 8 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +37.13% | Apr 14, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $16 → $12 | Hold | Maintains | $16 → $12 | +26.58% | Mar 6, 2025 |
| UBS | UBS | Strong Buy Maintains $18 → $17 | Strong Buy | Maintains | $18 → $17 | +79.32% | Feb 26, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $14 → $13 | Hold | Maintains | $14 → $13 | +37.13% | Feb 26, 2025 |
| Stifel | Stifel | Strong Buy Maintains $16 → $15 | Strong Buy | Maintains | $16 → $15 | +58.23% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
4.57B
from 4.44B
Increased by 2.86%
Revenue Next Year
4.76B
from 4.57B
Increased by 4.29%
EPS This Year
0.84
from 0.68
Increased by 23.39%
EPS Next Year
0.97
from 0.84
Increased by 16.16%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.8B | 5.0B | 5.2B | ||
| Avg | 4.6B | 4.8B | 5.0B | ||
| Low | 4.4B | 4.5B | 4.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.3% | 9.0% | 8.8% | ||
| Avg | 2.9% | 4.3% | 4.3% | ||
| Low | -1.9% | -0.6% | -1.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.90 | 1.05 | 1.22 | ||
| Avg | 0.84 | 0.97 | 1.11 | ||
| Low | 0.78 | 0.84 | 0.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 32.8% | 25.1% | 25.0% | ||
| Avg | 23.4% | 16.2% | 13.7% | ||
| Low | 15.3% | 0.4% | -1.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.